MBT-0206
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
3079 Background: MBT-0206 is a highly innovative anti-neovascular cytostatic compound designed to target and destroy newly formed…
3163 Background: MBT-0206 is a highly innovative anti-neovascular cytostatic compound designed to target and destroy newly formed…
3163 Background: MBT-0206 is a highly innovative anti-neovascular cytostatic compound designed to target and destroy newly formed…
Background: Systemically administrated cationic lipid complexes accumulate selectively in angiogenic tumor endothelium. The…
In the current study we investigated the anti-cancer potential of a combination therapy of MBT-0206 with the standard…
1310 Systemically administrated cationic lipid complexes accumulate selectively in angiogenic tumor endothelium1,2. The…